TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical 
Development

Kaufmann, Stefan H. E.; Dockrell, Hazel M.; Drager, Nick; Ho, Mei Mei; McShane, Helen; Neyrolles, Olivier; Ottenhoff, Tom H. M.; Patel, Brij; Roordink, Danielle; Spertini, François; Stenger, Steffen; Thole, Jelle; Verreck, Frank A. W.; Williams, Ann; TBVA2020 Consortium

doi:10.3389/fimmu.2017.01203

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development

MPS-Authors

/persons/resource/persons81969

Kaufmann, Stefan H. E.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Front_Immunol_2017_8_1203.pdf
(Publisher version), 2MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Kaufmann, S. H. E., Dockrell, H. M., Drager, N., Ho, M. M., McShane, H., Neyrolles, O., et al. (2017). TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development. Frontiers in immunology, 8(Issue OCT): 1203. doi:10.3389/fimmu.2017.01203.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002E-0FD0-6

Abstract

There is no abstract available